article thumbnail

As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid sales model

Fierce Pharma

Despite Boehringer Ingelheim’s 2021 Humira biosimilar approval being heralded by some analysts as a “landmark achievement” for the field, the drug—dubbed Cyltezo—has struggled to gain traction than | Facing lackluster Cyltezo sales, Boehringer Ingelheim will prune its ranks in the U.S.

Sales 261
article thumbnail

AstraZeneca pulls leukemia drug Lumoxiti off market after disappointing sales

Fierce Pharma

AstraZeneca pulls leukemia drug Lumoxiti off market after disappointing sales. Fri, 01/13/2023 - 09:29.

Marketing 258
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan

Fierce Pharma

Demand is so strong for Novo Nordisk’s obesity drugs that the only limitation on sales—in the short term—seems to be the company’s ability to produce them. Morgan, which has doubled its market projection for GLP-1 diabetes and obesity treatments to $71 billion for 2032.

Marketing 340
article thumbnail

Novo Nordisk, Eli Lilly's obesity drugs will lead in new drug sales in 2024: Evaluate

Fierce Pharma

Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales. Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales.

Sales 296
article thumbnail

Forrester Research Report: How Sales and Marketing Intelligence Drive Improved Business Outcomes

Fact: Only 8% of sales and marketing professionals say their data is between 91% - 100% accurate. In 2019, DiscoverOrg commissioned Forrester Consulting to evaluate sales and marketing intelligence practices in the B2B space. More organizations are investing in B2B sales and marketing intelligence solutions.

article thumbnail

As sales crater, Moderna sees hope in private COVID vaccine market and RSV launch

Fierce Pharma

Even as Moderna chugs through another post-pandemic year, the biotech has raised its COVID-19 vaccine revenue projection in the expectation that it can deliver a strong showing in the private marke | The company raised its forecast for COVID-19 sales to between $6 billion and $8 billion, up from a prior estimate of $5 billion.

Sales 244
article thumbnail

Episode 55 – Driving Sales with Physician Micro-Marketing in MedTech

Medical Device Success

Physician micro-marketing is a solution. Our guest to help us with this fascinating and surprising subject is Scott Alexander, CEO of Jairus Physician Micro-Marketing. All this done rapidly and economically when compared to traditional marketing and sales tactics. Jairus Physician Micro-Marketing website link.

article thumbnail

Marketing Ops: The New Revenue Hero

As data continues to play a starring role in today’s B2B organizations, both marketing and sales operations professionals are poised to solidify their place as critical revenue drivers.

article thumbnail

B2B Pocket Playbook: End-to-End Guide to Sales Enablement

Sales enablement is the strategic process of providing sales teams with the content, guidance, and mentorship needed to engage targeted buyers. It’s all about equipping sales professionals with the tools they need to put their best-selling foot forward. Get started today.

article thumbnail

Marketing-Led COVID-19 Growth Strategies: 2022 and Beyond

Businesses are tasked with beating pre-pandemic numbers, making marketing more essential than ever before. This is your chance to create unprecedented brand awareness, bring in the best leads sales has ever seen, and play an instrumental role in generating new and existing business revenue. Level up your marketing automation.

article thumbnail

Outrun Your Competition: Best Practices for Accelerating Sales Processes

Longer sales cycles. Every go-to-market team knows the frustrations that come from a drawn-out sales process. Larger buying committees. Slow-moving compliance reviews. How can you speed it up?

article thumbnail

100 Pipeline Plays: The Modern Sales Playbook

Meet your modern sales playbook - See how high-performing sales and marketing teams increase pipeline year-over-year. Use our proven data-driven plays to grow your pipeline and crush your revenue targets. Close more deals with these winning plays!

article thumbnail

Marketing-Led Post-COVID-19 Growth Strategies

Any return to normalcy may seem far-off, but sales and marketing are on the front lines of restarting the economy. However, there’s no team better suited to lead that charge than the marketing department. However, there’s no team better suited to lead that charge than the marketing department.

article thumbnail

The New GTM Playbook: 18 Ways to Future-Proof Your Sales Team

Longer sales cycles. Go-to-market teams of every size, in every industry, are grappling with these challenges firsthand. Increasingly discerning buyers. More meetings. Intensifying competition. Economic uncertainty. Thankfully, there’s an answer.

article thumbnail

The 5 Stages of Account-Based Marketing — and How to Win Them All

The benefits of account-based marketing are clear: internal alignment, shorter sales cycles, higher conversion rates. And yet only 43% of marketers are completely satisfied with the quality of their data. But none of this is possible without the most important element of a successful ABM program: good data.